代谢组学与2型糖尿病风险:前瞻性队列研究的更新系统综述与Meta分析
该更新系统综述与Meta分析检索PubMed和Embase至2021年3月6日,纳入61篇报告、71196名参与者和11771例2型糖尿病事件,对412种代谢物进行Meta分析,其中123种与2型糖尿病风险显著相关(错误发现率校正P<0.05)。多种氨基酸、碳水化合物及能量相关代谢物、酰基肉碱、甘油酯、磷脂酰乙醇胺和神经酰胺水平升高与风险升高相关(HR 1.07-2.58),而甘氨酸、谷氨酰胺、甜菜碱、吲哚丙酸和磷脂酰胆碱水平升高与风险降低相关(HR 0.69-0.90)。
要点
- 123种血浆或血清代谢物与2型糖尿病风险显著相关(错误发现率校正P<0.05)。
- 支链氨基酸、芳香族氨基酸、甘油酯、酰基肉碱和神经酰胺水平升高与风险升高相关(HR 1.07-2.58)。
- 甘氨酸、谷氨酰胺、甜菜碱、吲哚丙酸和磷脂酰胆碱水平升高与风险降低相关(HR 0.69-0.90)。
核心结论
- 多种血浆和血清代谢物,包括氨基酸、脂质和碳水化合物,与2型糖尿病风险相关。
研究设计与样本
- 更新系统综述与Meta分析,检索PubMed和Embase至2021年3月6日,纳入前瞻性观察研究,共61篇报告、71196名参与者、11771例2型糖尿病病例/事件,对412种代谢物进行Meta分析。
主要发现
- 123种代谢物与2型糖尿病风险显著相关(错误发现率校正P<0.05)。
- 支链氨基酸、芳香族氨基酸、丙氨酸、谷氨酸、赖氨酸和蛋氨酸、甘露糖、海藻糖和丙酮酸、酰基肉碱(C4-DC、C4-OH、C5、C5-OH和C8:1)、多数甘油酯(二酰甘油和三酰甘油)、(溶血)磷脂酰乙醇胺及神经酰胺水平升高与2型糖尿病风险升高相关(HR 1.07-2.58)。
- 甘氨酸、谷氨酰胺、甜菜碱、吲哚丙酸和(溶血)磷脂酰胆碱水平升高与2型糖尿病风险降低相关(HR 0.69-0.90)。
局限性
- 部分代谢物观察到显著异质性(I2 > 50%,τ2 > 0.1)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Due to the rapidly increasing availability of metabolomics data in prospective studies, an update of the meta evidence on metabolomics and type 2 diabetes risk is warranted. PURPOSE: To conduct an updated systematic review and meta-analysis of plasma, serum, and urine metabolite markers and incident type 2 diabetes. DATA SOURCES: We searched PubMed and Embase until 6 March 2021. STUDY SELECTION: We selected prospective observational studies where investigators used high-throughput techniques to investigate the relationship between plasma, serum, or urine metabolites and incident type 2 diabetes. DATA EXTRACTION: Baseline metabolites per-SD risk estimates and 95% CIs for incident type 2 diabetes were extracted from all eligible studies. DATA SYNTHESIS: A total of 61 reports with 71,196 participants and 11,771 type 2 diabetes cases/events were included in the updated review. Meta-analysis was performed for 412 metabolites, of which 123 were statistically significantly associated (false discovery rate-corrected P < 0.05) with type 2 diabetes risk. Higher plasma and serum levels of certain amino acids (branched-chain, aromatic, alanine, glutamate, lysine, and methionine), carbohydrates and energy-related metabolites (mannose, trehalose, and pyruvate), acylcarnitines (C4-DC, C4-OH, C5, C5-OH, and C8:1), the majority of glycerolipids (di- and triacylglycerols), (lyso)phosphatidylethanolamines, and ceramides included in meta-analysis were associated with higher risk of type 2 diabetes (hazard ratio 1.07-2.58). Higher levels of glycine, glutamine, betaine, indolepropionate, and (lyso)phosphatidylcholines were associated with lower type 2 diabetes risk (hazard ratio 0.69-0.90). LIMITATIONS: Substantial heterogeneity (I2 > 50%, τ2 > 0.1) was observed for some of the metabolites. CONCLUSIONS: Several plasma and serum metabolites, including amino acids, lipids, and carbohydrates, are associated with type 2 diabetes risk.
引用
- Morze J, Wittenbecher C, Schwingshackl L, et al. Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care. 2022. PMID: 35349649. doi:10.2337/dc21-1705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。